1. Home
  2. SNGX vs KAVL Comparison

SNGX vs KAVL Comparison

Compare SNGX & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.59

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Logo Kaival Brands Innovations Group Inc.

KAVL

Kaival Brands Innovations Group Inc.

HOLD

Current Price

$0.14

Market Cap

9.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
KAVL
Founded
1987
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.8M
9.6M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
SNGX
KAVL
Price
$1.59
$0.14
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
304.0K
164.5K
Earning Date
11-07-2025
09-16-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,127,037.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$0.20
52 Week High
$6.23
$1.55

Technical Indicators

Market Signals
Indicator
SNGX
KAVL
Relative Strength Index (RSI) 54.31 17.08
Support Level $1.55 $0.47
Resistance Level $1.67 $0.51
Average True Range (ATR) 0.11 0.05
MACD 0.02 -0.03
Stochastic Oscillator 75.00 2.18

Price Performance

Historical Comparison
SNGX
KAVL

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About KAVL Kaival Brands Innovations Group Inc.

Kaival Brands Innovations Group Inc is focused on growing and incubating creative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.

Share on Social Networks: